http://www.vaccinesafety.edu/thi-table.htm
Vaccine |
Brand Name (click on
name for pagkage insert) |
Manufacturer |
Thimerosal
Concentration1 |
Mercury |
Date Approved or Changed |
pg in 2002 PDR |
Anthrax |
Anthrax vaccine |
BioPort Corporation |
0 |
0 |
|
|
| DTaP | Acel-Imune | Wyeth-Ayerst | .01% | 25 | no longer produced | 1851 |
| Tripedia | Aventis Pasteur | * | --* | 03-28-00 | 817 | |
| Certiva | Baxter | .01% | 25 | 07-29-98 – no longer produced | ||
|
Infanrix |
GlaxoSmithKline |
0 |
0 |
01-29-97 |
1562 |
DTwP |
All Products |
|
.01% |
25 |
|
|
DT |
All Products |
|
.01% |
25 |
|
|
Td |
All Products |
|
.01% |
25 |
|
|
TT |
All Products |
|
.01% |
25 |
|
|
DTwP-Hib |
Tetramune |
Wyeth-Ayerst |
.01% |
25 |
no longer
produced |
|
Hib |
ActHIB/OmniHib |
Aventis Pasteur |
0 |
0 |
09-27-96 |
798 |
| ProHIBiT | Aventis Pasteur | .01% | 25 | no longer produced | ||
| TriHIBit | Aventis Pasteur | * | * | 817 | ||
| HibTITER multi-dose single dose |
Wyeth-Ayerst Wyeth-Ayerst |
.01% 0 |
25 0 |
1859 | ||
| PedvaxHIB liquid(2) | Merck | 0 | 0 | 03-98 (web) | 2148 | |
| COMVAX(3) | Merck | 0 | 0 | 10-02-96 | 2056 | |
Hepatitis A |
GlaxoSmithKline |
0 |
0 |
1544 |
||
| Vaqta adult/pediatric | Merck | 0 | 0 | 03-29-96 | 2199 | |
Hepatitis B |
Engerix-B preservative free |
GlaxoSmithKline
|
03-28-00 |
1517 |
||
| Engerix-B | GlaxoSmithKline | .005% | 12.5 | no longer produced | ||
| Recombivax HB preservative free | Merck | 0 | 0 | 08-27-99 | 2178 | |
| Recombivax HB | Merck | .005% | 12.5 | |||
Hep
A-B |
GlaxoSmithKline |
0 |
0 |
05-11-2001 |
1674
|
|
Influenza |
All products in U.S. |
|
.01% |
25 |
|
|
IPV |
Aventis Pasteur |
0 |
0 |
|
809 |
|
Lyme |
GlaxoSmithKline |
0 |
0 |
12-21-98 |
1592 |
|
Meningococcal |
Aventis Pasteur |
|
813 |
|||
MMR |
Merck |
0 |
0 |
|
2118 |
|
Measles |
Merck |
0 |
0 |
|
2044 |
|
OPV |
Wyeth-Ayerst |
0 |
0 |
no longer
produced |
|
|
Pneumococcal |
Wyeth-Ayerst |
0 |
0 |
02-17-00 |
1870 |
|
| Pnu-mune 23 | Wyeth-Ayerst | .01% | 25 | 1868 | ||
| Pneumovax 23 |
Merck | 0 | 0 | 1986 | 2156 | |
Rabies
|
Rabies Vaccine Adsorbed |
Bioport Corporation |
.01% |
25 |
03-18-88 |
|
| RabAvert | Chiron | 0 | 0 | 10-20-97 | 1203 | |
| Aventis Pasteur | 0 | 0 | 07-91 (PDR) | 807 | ||
Rotavirus |
Rotashield |
Wyeth-Ayerst |
0 |
0 |
08-31-98 withdrawn 10-15-99 |
|
Typhoid |
Vivotef Berna |
Berna |
0 |
0 |
04-97
(PDR) |
997 |
Typhoid Fever |
Typhim Vi |
Aventis Pasteur |
0 |
0 |
06-95 (PDR) |
825 |
| Typhoid vaccine | Wyeth-Ayerst | 0 | 0 | 02-09-94 (PDR) | ||
Varicella |
Merck |
0 |
0 |
03-17-95 |
2202 |
|
Yellow
Fever |
Aventis
Pasteur |
0 |
0 |
05-96 (PDR) |
827 |
___ - shaded text indicates vaccines no longer in production
1. A concentration of 1:10,000 is
equivalent to a 0.01% concentration. Thimerosal is approximately 50% Hg by weight.
A 1:10,000 concentration contains 25 micrograms of Hg per 0.5 mL.
2. A previously marketed lyophilized preparation contained 0.005%
thimerosal. (*Prior to 02-04-02 this web page incorrectly referenced
PedvaxHIB liquid as having contained 0.05% thimerosal.)
3. COMVAX is not approved for use under 6 weeks of age because of
decreased response to the Hib component.
* This product should be considered
equivalent to thimerosal-free products. This
vaccine may contain trace amounts (<0.3 mcg) of mercury left
after post-production thimerosal removal; these amounts have no biological effect. JAMA 1999;282(18) and JAMA 2000;283(16).